| 1 | Ordinary | Adoption of standalone financial statements for the year ended 31 March 2021 |  |
| 2 | Ordinary | Adoption of consolidated financial statements for the year ended 31 March 2021 |  |
| 3 | Ordinary | Ratify first interim dividend of Rs.0.8 per equity share of face value Rs. 2.0 each |  |
| 4 | Ordinary | Ratify second interim dividend of Rs.0.4 per equity share of face value Rs. 2.0 each |  |
| 5 | Ordinary | Approve and ratify third interim dividend of Rs.0.8 per equity share of face value Rs. 2.0 each |  |
| 6 | Ordinary | Reappoint Dr. Satyanarayana Chava (DIN 00211921) as Director liable to retire by rotation |  |
| 7 | Ordinary | Reappoint Dr. Lakshmana Rao C V (DIN 06885453) as Director liable to retire by rotation |  |
| 8 | Ordinary | Approve remuneration of Rs. 550,000 payable to Sagar & Associates, cost auditors for FY21 |  |
| 9 | Special | Remove the cap on the bonus payable to Dr. Satyanarayana Chava (DIN 00211921), Executive Director and CEO with effect from 1 April 2020 till the end of his current term |  |
| 10 | Special | Remove the cap on the bonus payable to V V Ravi Kumar (DIN 01424180), Executive Director and CFO with effect from 1 April 2020 till the end of his current term |  |
| 11 | Special | Remove the cap on the bonus payable to Dr. Lakshmana Rao C V (DIN 06885453), Executive Director with effect from 1 April 2020 till the end of his current term |  |
| 12 | Special | Reappoint Ms. Aruna Bhinge (DIN: 07474950) as an Independent Director for five years w.e.f. 7 July 2021 |  |
| 13 | Special | Reappoint Rajesh Koshy Chandy (DIN: 07575240) as an Independent Director for five years w.e.f. 27 July 2021 |  |
| 14 | Special | Approve Laurus Labs Employees Stock Option Scheme 2021 (ESOP 2021 Scheme) |  |
| 15 | Special | Approve extension of ESOP 2021 to the employees of the subsidiaries of the company |  |
| 16 | Special | Alteration of Articles of Association to remove Bluewater Investment Limited’s right to nominate a director |  |